Back to Search Start Over

Patent Issued for Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases (USPTO 11084860)

Source :
Medical Patent Business Week. September 3, 2021, 7312
Publication Year :
2021

Abstract

2021 SEP 3 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Donahoe, [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Medical Patent Business Week
Publication Type :
News
Accession number :
edsgcl.673626681